Posted on November 4th, 2008 by Health News
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM’s licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
Read more
Filed under: General Health News
Tags: brain, General Health News
Related posts
- Workers exposed to lead show more cognitive problems later in life (0)
(American Psychological Association) Both the developing brain and the aging brain can suffer from lead exposure. For older people, a buildup of lead from earlier exposure may be enough to result in greater cognitive problems after age 55, according to a follow-up study of adults exposed to lead at work.
Read more
[tags] General Health News [/tags]
- Women less likely to receive critical care after a stroke, MSU researchers find (0)
(Michigan State University) Women are 30 percent less likely than men to receive a critical clot-busting drug than can limit brain damage after a stroke, according to a Michigan State University study.The study findings were presented Feb. 19 in San Diego at the International Stroke Conference.
Read more
[tags] General Health News [/tags]
- When ‘just say no’ isn’t enough: Try science (0)
(American Association for the Advancement of Science) Teens are fascinated by their brains, the way they work, change, and even "freeze" sometimes. The American Association for the Advancement of Science (AAAS) recommends that parents, teachers and caregivers use that fascination to engage middle and high school students this holiday season in a discussion of why [...]
- What happens when we sleep (0)
(McGill University) Lack of sleep is a common complaint but for many, falling asleep involuntarily during the day poses a very real and dangerous problem. A new study from the Montreal Neurological Institute at McGill University demonstrates interestingly, that sleep-wake states are regulated by two different types of nerve cells (neurons), melanin-concentrating hormone neurons and [...]
- Welding Fumes May Cause Early Parkinson-Like Brain Damage (0)
A study shows damage to the dopamine system in the brain of healthy welders and manganese-laden fumes may be the culprit. Medscape Medical News
Read more
[tags] General Health News [/tags]
Leave a Reply